Skin changes induced by a zinc oxide dressing compared with a hydrocolloid dressing in healthy individuals.
OBJECTIVE
Incidence of skin complications in ostomy patients constitutes a well-known and well-described problem. The reasons are, however, very difficult to describe because of the many factors contributing to the problem. This article describes the skin changes derived exclusively from the adhesives used in a carefully controlled, long-term study using two fundamentally different types of adhesives: a hydrocolloid adhesive and a zinc oxide adhesive.


METHODS
The adhesives were changed daily on the volar forearm of 11 volunteers for a 4-week period. Once a week, transepidermal water-loss (TEWL), water content of the skin, erythema and the peel force applied for removal of the adhesives were measured. On the last day of the study, a replica of the skin surface was obtained to determine changes in the skin topography, and a biopsy was taken to study changes at the cellular level.


CONCLUSIONS
We found increased TEWL and decreased water content in skin treated with the zinc oxide adhesive, but increased water-loss and water content when the hydrocolloid adhesive was used. In addition, the area treated with zinc oxide adhesive showed significant increase of epidermal thickness, scaly appearance and parakeratosis with similarities to pathological dry skin diseases such as psoriasis and atopic dermatitis, changes that were not found when using the hydrocolloid adhesive. The skin response seems to be the result of the content of zinc oxide and the mechanical interaction of the zinc oxide adhesive. We conclude that the nature of the adhesive plays an important role in the skin response to repeated application of adhesives, as seen in peristomal skin.
Nielsen
Lene Feldskov
LF
Coloplast Research, Coloplast A/S, Humlebaek, Denmark. dklfn@coloplast.com
Blume
Niels
N
Romme
Tina
T
Samuelsen
Peter
P
Everland
Hanne
H
Ifversen
Peter
P
Karlsmark
Tonny
T
D000268:Adhesiveness; D000269:Adhesives / Q000009:adverse effects*; D000328:Adult; D001458:Bandages / Q000009:adverse effects*; D003102:Colloids / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000166:cytology* / Q000187:drug effects*; D012879:Skin Physiological Phenomena / Q000187:drug effects*; D015034:Zinc Oxide / Q000009:adverse effects*
D000269:Adhesives; D003102:Colloids; D015034:Zinc Oxide